ImmuneOncia Therapeutics Inc.
Company Management

ImmuneOncia Therapeutics Inc.

Pharmaceutical Manufacturing Kr 19 employees
Employees
19
Contacts
1
Emails
1

ImmuneOncia Therapeutics Inc. Overview

Headquarters
Kr
Phone Number
Available in AeroLeads
Industry
Pharmaceutical Manufacturing
Employees
19
Founded
2016
Funding
20.6M
Company Email
Available in AeroLeads
NAICS
Pharmaceutical and Medicine Manufacturing
Medicinal and Botanical Manufacturing
Pharmaceutical Preparation Manufacturing

About ImmuneOncia Therapeutics Inc.

ImmuneOncia is an immuno-oncology-centric biopharmaceutical company. Established in 2016 as a joint venture company between Yuhan and Sorrento, ImmuneOncia will leverage both companies’ expertise in drug development and antibody engineering. Our mission is to bring safe, effective, and novel immunotherapies to oncology patients world-wide. ImmuneOncia’s portfolio includes diverse immune checkpoint antibodies; the lead antibody IMC-001 Phase I study was completed in Feb 2019 and its Phase 2 study is being prepared. ImmuneOncia is also developing several antibodies targeting novel immune-checkpoints.

ImmuneOncia Therapeutics Inc. Contact Details

People in AeroLeads
4
With contact data
1
Email contacts
1
25.0% coverage

ImmuneOncia Therapeutics Inc. Org Chart

Sample employees and titles
Name Title Contact
Yangkyun Ryu 이뮨온시아/Bio Production/이사
View
Sung Ho Kim Cto/immuneoncia Therapeutics Inc.
View
Donghyun Yoon Finance Head at Immuneoncia
Email
Seyoon (Scott) Kim Vice President, Head of Business
View

Employees by Management Level

Senior / Lead 4 profiles
Executive 3 profiles
Individual contributor 3 profiles
VP / Head 1 profile

Compare Similar Companies to ImmuneOncia Therapeutics Inc.